Introduction
PKC comprises a family of serine/threonine protein kinases, which participate in transducing intracellularly a wide number of extracellular signals (Mellor and Parker, 1998) . They have been shown to participate in signaling events as diverse as cell proliferation, apoptosis, smooth muscle contraction, and secretion (Dekker and Parker, 1994; Toker, 1998) . Up to 12 distinct family members have been discovered in mammalian cells. They have been subdivided into three classes: (1) the classical or conventional PKCs ( ␣ , ␤ I, ␤ II, and ␥ ) activated by Ca 2 ϩ and diacylglycerol; (2) the new or novel PKCs ( ␦ , , , and ) activated by diacylglycerol but Ca 2 ϩ independent; and (3) the atypical PKCs ( and ), which are Ca 2 ϩ and diacylglycerol insensitive (Nishizuka, 1992) .
On the one hand, Ca 2 ϩ is a crucial activator of some PKC isoforms; on the other hand, PKC-dependent phosphorylation reactions have been shown to modify the spatio-temporal pattern of cellular Ca 2 ϩ responses. Indeed, PKCs were shown to differentially decode high and low frequency Ca 2 ϩ spiking (Oancea and Meyer, 1998) and to modulate Ca 2 ϩ release from the ER evoked by agonist stimulation (Montero et al., 2003) . Thus, they appear to be an important part of the molecular machinery underlying the wide complexity of Ca 2 ϩ signaling Clapham, 1995; Berridge et al., 2000) . As the site of action, much remains to be explored. Indeed, PKCs were shown to associate to cellular domains and organelles playing a crucial role in generating and decoding Ca 2 ϩ signals, such as the plasma membrane, the ER, the Golgi apparatus, and the mitochondria (Goodnight et al., 1995; Wang et al., 1999; Perego et al., 2002) .
In this contribution, we took advantage of intracellularly targeted Ca 2 ϩ probes (the aequorin chimeras) and a panel of PKC-GFP fusion proteins to explore the effects of the various PKC isoforms on the Ca 2 ϩ signals occurring in different cellular domains. Specifically, we constructed a panel of PKC-GFP chimeras that allow the molecular repertoire of these effectors to be altered. The chimeras include the ␣ , ␤ , ␦ , , and isoforms (Chiesa et al., 2001 ). For measuring Ca 2 ϩ concentration, we used aequorin-based recombinant probes (Rizzuto et al., 1992; Brini et al., 1995; Montero et al., 1995; Pinton et al., 1998) that can be cotransfected with the protein of interest, thus providing an accurate monitoring of Ca 2 ϩ signaling in the transfected subset of cells, and probes that are specifically targeted to a defined subcellular compartment, thus providing a complete analysis of intracellular Ca 2 ϩ homeostasis. In our work, we analyzed the effects of the various isoforms on organelle Ca 2 ϩ handling, with special focus on mitochondria. These organelles act as an important "decoding station," where Ca 2 ϩ signals can exert effects as diverse as stimulation of aerobic metabolism (Jouaville et al., 1999) and release of proapoptotic factors to the cytoplasm (Kroemer and Reed, 2000) .
By this means, we observed that the overexpression of different PKC isoforms induces specific alterations of cellular Ca 2 ϩ homeostasis. In particular, we observed an effect of some isoforms on mitochondrial Ca 2 ϩ responses. Then, we addressed the mechanisms that allow this fine modulation of mitochondrial Ca 2 ϩ homeostasis and analyzed some possible targets of PKC action, such as the mitochondrial membrane potential ( ⌬⌿ m ; i.e., the driving force for the Ca 2 ϩ uptake into the organelle), the production of reactive oxygen species (ROS), and the three-dimensional structure of the organelle. Finally, we obtained evidence for the involvement of the ␤ isoform of PKC in the yet poorly understood phenomenon of desensitization of mitochondrial Ca 2 ϩ responses (Maechler et al., 1998; Challet et al., 2001) .
Results

Different effects of PKC isoforms on mitochondrial Ca
2 ϩ signaling The initial goal of our work was to evaluate whether or not the various PKC isoforms could differently affect Ca 2 ϩ handling in mitochondria, which is an important site for decoding cellular Ca 2 ϩ signals. For this purpose, a defined PKC isoform was overexpressed through the panel of PKC-GFP chimeras developed in the laboratory, and mitochondrial Ca 2 ϩ homeostasis was monitored through a cotransfected mitochondrially targeted aequorin (AEQ) probe, mtAEQ. Specifically, HeLa cells were either cotransfected with the PKC-GFP chimera of interest and mtAEQ (PKC overexpressing) or transfected with mtAEQ alone (control). After transfection and reconstitution of the photoprotein (see Materials and methods for details), the coverslip with the transfected cells was transferred to the luminometer chamber and data were collected. In all cases, the mitochondrial Ca 2 ϩ response to histamine, an agonist acting on Gq-coupled receptor and causing the production of inositol 1,4,5 trisphosphate (IP3), was investigated ( Fig. 1) ] values as described in Materials and methods. Where indicated, the cells were challenged with 100 M histamine. In this and in the following aequorin experiments, the traces are representative of at least 10 from 3 independent experiments, which gave similar results. Figure 2 . Effects of PKC␣, ␤, and inhibitors on mitochondrial Ca 2؉ homeostasis. HeLa cells were transfected with the mtAEQ chimera. 16 h before the aequorin measurement (performed 36 h after transfection), the cells were treated with 10 M Ro-32-0432 (PKC␣ inhibitor), 5 M hispidin (PKC␤ inhibitor), or 50 M PKC pseudosubstrate inhibitor myristoylated (PKC inhibitor), as labeled. Where indicated, the cells were challenged with 100 M histamine. All other conditions were as in Fig. 1 ] rise was markedly larger (peak amplitude: 109 Ϯ 9 M; n ϭ 15, P Ͻ 0.05).
To rule out the possibility that we were observing spurious effects due to major overexpression of active kinases (and thus a global perturbation of cellular functions), we aimed at confirming these observations in cells expressing only endogenous kinases by using isoform-specific PKC inhibitors. The expectation was to observe an effect opposite to that caused by the recombinant overexpression of the kinase. In these experiments, mtAEQ-expressing HeLa cells were treated 16 h before the Ca 2ϩ measurements with 10 M Ro-32-0432 (Birchall et al., 1994) , 5 M hispidin (Gonindard et al., 1997) , or 50 M PKC pseudosubstrate inhibitor myristoylated (Sajan et al., 1999) to inhibit endogenous PKC␣, ␤, or , respectively (Fig. 2) . [Ca 2ϩ ] m responses to histamine stimulations were evaluated as in Fig. 1 . The results obtained well match those obtained by overexpressing the different PKC isoforms. Indeed, the inhibition of PKC␣ and ␤ caused a significant increase of the [Ca 2ϩ ] m rise evoked by histamine (peak amplitude: 152 Ϯ 14 M [PKC␣] and 107 Ϯ 9 M [PKC␤]; n ϭ 7, P Ͻ 0.05). Interestingly, the increase caused by the inhibitors appears larger in the case of inhibition of PKC␣ than of PKC␤ both in absolute terms and as a percent (77 vs. 21% increase, respectively). These are fully specular results to the overexpression experiments of PKC␣ and PKC␤, indicating a more pronounced inhibitory effect of PKC␣. Vice versa the inhibition of PKC drastically reduced the [Ca 2ϩ ] m rise (peak amplitude: 66 Ϯ 4 M; n ϭ 11, P Ͻ 0.05). The inhibition of the PKC␦ (with Rottlerin) was not, in our hands, informative, as the prolonged exposure to the inhibitor not only almost abolished both cytosolic and mitochondrial Ca 2ϩ responses but also was associated to high cell mortality.
The analysis of intracellular calcium stores and of cytosolic Ca 2ϩ responses indicates a specific mitochondrial effect for some PKC isoform We investigated whether or not the [Ca 2ϩ ] m changes were paralleled by alterations of cytosolic Ca 2ϩ signals. Indeed, the mitochondrial Ca 2ϩ response usually follows and amplifies the agonist-dependent cytosolic rise. In the experiment shown in Fig. 3 A, HeLa cells, either coexpressing the PKC chimera of interest and cytosolic aequorin (PKC overexpressing) or expressing only cytosolic aequorin (control) , were challenged with histamine. As expected based on mitochondrial results, there is no difference in the cytosolic Ca 2ϩ response between control and PKCoverexpressing cells (peak amplitude: 2.6 Ϯ 0.1 M [PKC] vs. 2.6 Ϯ 0.1 M [control]; n ϭ 18, P Ͼ 0.05). A significant reduction of the response was observed in the PKC␣-overexpressing cells (peak amplitude: 1.8 Ϯ 0.1 M; n ϭ 12, P Ͻ 0.05). Surprisingly, in contrast with the mitochondrial results, in the cytosolic compartment there is only a small reduction in PKC␤-and PKC␦-overexpressing cells (peak amplitude: 2.2 Ϯ 0.1 M; n ϭ 17, P Ͻ 0.05 for PKC␤ and 2.3 Ϯ 0.2 M; n ϭ 15, P Ͼ 0.05 for PKC␦) ] m peak, from 19% (after 5 min in KRB/EGTA) to 38% (after 50 min). It is apparent that for an ‫%51ف‬ reduction of the [Ca 2ϩ ] c peak (i.e., slightly larger than that observed in PKC␤-and PKC␦-overexpressing cells), the decrease of the [Ca 2ϩ ] m peak was ‫%42ف‬ (compared with an ‫36ف‬ and 53% reduction in PKC␤-and PKC␦-overexpressing cells, respectively). We verified if the PKC isoforms could alter the kinetics of the [Ca 2ϩ ] c rise (an effect that could be overlooked by the low temporal resolution of the aequorin measurements). For this purpose, we performed single cell fura-2 imaging studies, comparing the [Ca ] c rise. Overall, these experiments indicate that no major feature of cytosolic Ca 2ϩ signaling is significantly affected by the overexpression of these PKC isoforms; thus, the major reduction of the [Ca 2ϩ ] c responses must be ascribed to a direct effect on mitochondrial Ca 2ϩ homeostasis. To confirm the latter conclusion, we also investigated the effect of PKC overexpression on the agonist- (Brini et al., 2000) .
Thus, we monitored the [Ca 2ϩ ] of agonist-sensitive Ca 2ϩ stores, using the aequorin chimeras targeted to the endoplasmic reticulum (erAEQ; Montero et al., 1995) or to the Golgi apparatus (GoAEQ; Pinton et al., 1998) . For this purpose, HeLa cells were either cotransfected with the PKC chimera of interest and erAEQ (or GoAEQ; PKC-overexpressing) or transfected with erAEQ (or GoAEQ) alone (control; see Materials and methods). Figs. 4 and 5 show the calibrated [Ca 2ϩ ] values in the two compartments. To obtain reliable quantitative estimates of the [Ca 2ϩ ] in the lumen of these two organelles, their [Ca 2ϩ ] needs to be decreased during both the reconstitution of aequorin with coelenterazine and the subsequent initial phase of perfusion with KRB/ EGTA in the luminometer (see Materials and methods). Under those conditions, the [Ca 2ϩ ] was Ͻ10 M in both organelles. When the [Ca 2ϩ ] in the perfusion medium was switched to 1 mM, the [Ca 2ϩ ] in the lumen of the two compartments gradually increased. The [Ca 2ϩ ] in the lumen of the two compartments, in control cells, reached a plateau value of 419 Ϯ 10 M (n ϭ 39) in the ER and 228 Ϯ 8 M (n ϭ 27) in the Golgi apparatus. In PKC-transfected cells, Ca 2ϩ was reaccumulated in the organelles with a similar time course, and comparable steady-state values were attained in both compartments (ER: 392 stores, the basal Ca 2ϩ leak from the ER was also investigated. In these experiments, after aequorin reconstitution, the ER was refilled with Ca 2ϩ as described in the previous paragraph. Then, the SERCA inhibitor 2,5-di-(tert-butyl)-1,4-benzohydroquinone was added to the perfusion medium to initiate passive Ca 2ϩ efflux from the ER. No difference in the leak rate between PKCs transfected and control cells was observed (unpublished data).
Together, the aforementioned data indicate that the differences previously observed in cellular Ca 2ϩ homeostasis, induced by overexpression of the different PKC isoforms, are not due to changes in the filling state of the intracellular Ca 2ϩ stores. These results are particularly interesting (and partially unexpected) in the case of PKC␣-overexpressing cells, in which a very marked reduction of mitochondrial and cytosolic responses to agonists had been observed.
We investigated the release phase (i.e., the [Ca 2ϩ ] ER decrease occurring after agonist stimulation; Fig. 4 ). The rapid [Ca 2ϩ ] ER drop after histamine addition was larger (73
; n ϭ 9, P Ͻ 0.05) in control cells compared with PKC␣-transfected cells, indicating a substantially reduced release through the IP3-gated channels. These data are fully consistent with the cytosolic and mitochondria reduction of Ca 2ϩ responses and suggest a direct, inhibitory effect on one of the components of the signaling cascade from the plasma membrane receptor to the Ca 2ϩ release channels (i.e., from IP3 production to the activity of the IP3-gated channels).
On the contrary, with the other PKC isoforms, little or no effect on Ca 2ϩ release was observed: a small reduction in ER Ca 2ϩ release in PKC␤-transfected cells (85 Ϯ 6 M; n ϭ 9, P Ͼ 0.05) and no difference with all others isoforms (139 Ϯ 10 M [PKC␦], 129 Ϯ 13 [PKC] , and 118 Ϯ 8 M [PKC]; n ϭ 9, P Ͼ 0.05). Similar results were obtained from the analysis of the Golgi store. Also in this case, the only significant effect was a smaller Ca 2ϩ release in PKC␣-overexpressing cells (Fig.5) .
Together, these data show that although PKC␣ globally affects cellular Ca 2ϩ signaling, the other isoforms (i.e., the ␤, ␦, and ) appear to modulate mitochondrial Ca 2ϩ responses without significantly altering cellular Ca 2ϩ homeostasis, most likely acting directly on this organelle.
Mitochondrial membrane potential, ROS production, and organelle morphology in PKC-expressing cells Next, the nature of this mitochondrial effect was investigated. At first, we verified the occurrence of ⌬⌿ m changes in PKC-GFP-transfected and control cells. Using the ⌬⌿ msensitive dyes (TMRM and JC-1), no statistically significant difference was detected between control and PKC-expressing cells (identified by the GFP tag), although a small number of cells with detectable ⌬⌿ m decreases was observed upon PKC␣ and ␤ transfection. To be able to detect small changes, we decided to measure free radical production in mitochondria using the ROS-sensitive fluorescent probe CM-H 2 DCFDA. ROS (ROS: O 2 Ϫ *, H 2 O 2 , OH*) are generated from chemical reactions of molecular oxygen with the enzymes and coenzymes of the respiratory chain. This process is physiological and continuous (Skulachev, 1998) , and mitochondrial ROS production was shown to strictly depend in a nonlinear way on ⌬⌿ m . Indeed, even small ⌬⌿ m decreases cause a large (measurable) inhibition of mitochondrial ROS production, whereas ⌬⌿ m increases cause a significant stimulation of ROS production (Korshunov et al., 1997) .
Thus, we performed single cell analysis of mitochondrial ROS production in PKC-overexpressing cells. Mitochondrial contribution was estimated by evaluating the effect of the collapse of ⌬⌿ m with FCCP on total ROS production, as detailed in Materials and methods. Although a great variability was observed between individual cells, Ͼ80% cells showed a mitochondrial ROS production ranging between 10 and 40% of total cellular production. No significant difference was detected upon overexpression of PKC and . Con- versely, mitochondrial ROS production appeared greatly decreased upon overexpression of PKC␣ and ␤ ‫05ف(‬ and 25% of cells, respectively, compared with Ͻ10% of control cells, had a mitochondrial ROS production Ͻ10%). Upon overexpression of PKC␦, mitochondrial ROS production was increased ‫%54ف(‬ of PKC␦-expressing cells, compared with Ͻ10% of control cells, had a mitochondrial ROS production Ͼ50%). Although a ⌬⌿ m change could not be directly shown with TMRM, these data suggest that, in the case of PKC␤, a small reduction in the driving force for Ca 2ϩ accumulation may occur, which could be in part responsible for the reduction of mitochondrial Ca 2ϩ accumulation. Finally, we wished to rule out the possibility that the alteration of mitochondrial Ca 2ϩ responses was a consequence of a major structural perturbation of the organelle (that could cause the loss of the ER-mitochondria contacts, essential for the large and prompt uptake of Ca 2ϩ by mitochondria). Mitochondrial structure was evaluated by labeling the organelle with TMRM (that could be used in association with the PKC-GFPs) and visualizing it with a confocal microscope. Fig. 6 shows the mitochondrial fluorescence image obtained from cells overexpressing the different PKC-GFP chimeras. It is apparent that in all cases PKC overexpression caused no obvious alteration in mitochondrial morphology, despite the occurrence of occasional structural rearrangements both in transfected and nontransfected cells.
PKC␤ is involved in the desensitization of mitochondrial Ca
2ϩ uptake A phenomenon that attracted much interest in the study of mitochondrial Ca 2ϩ signaling is the drastic reduction in amplitude occurring when two consecutive stimuli are applied. Several factors contribute to this experimental observation: (a) the second stimulation with the same agonist evokes a smaller cytosolic response (due to receptor desensitization); this response has a greater effect on mitochondrial Ca 2ϩ accumulation, as shown in the experiment of Fig. 3 B. (b) When aequorin is used for measuring [Ca 2ϩ ] m , the higher probe consumption (and depletion) in the mitochondrial regions close to the ER may lead to an artifactual underestimation of the following response Filippin et al., 2003) . However, evidence has been obtained that this reduction, at least in part, represents a true desensitization of the mitochondrial Ca 2ϩ uptake machinery that has important physiological consequences (e.g., an inhibition of events that depend on mitochondrial Ca 2ϩ accumulation, such as insulin secretion; Maechler et al., 1998) . The mechanism of this inhibitory effects is still unknown, and we investigated the possibility that the PKC isoforms, which are activated upon agonist stimulation and specifically reduce the capacity of mitochondria of accumulating Ca 2ϩ , such as PKC␤, could be involved.
The working hypothesis was that if PKC␤ has a role in desensitizing mitochondrial Ca 2ϩ uptake, its inhibition during the first histamine stimulation should lead to an increase of the [Ca 2ϩ ] m rise observed during the second agonist challenge. On the contrary, the second [Ca 2ϩ ] c rise should not be affected. Thus, the cells were treated with the specific inhibitor of PKC␤ hispidin (applied 1 min before the first application of histamine, maintained throughout agonist stimulation, and washed away). The results are shown in Fig. 7 B. The short treatment with the PKC␤ inhibitor does not change the first response (consistent with the low PKC␤ expression in HeLa cells; Chun et al., 1996) . On the contrary, it markedly increases the [Ca 2ϩ ] m peak evoked by the second histamine stimulation (62 Ϯ 14 M vs. 38 Ϯ 8 M; n ϭ 12, P Ͻ 0.05), whereas no differences were observed in the cytosolic response (2.3 Ϯ 0.6 M vs. 2.3 Ϯ 0.9 M; n ϭ 9, P Ͼ 0.05; Fig. 7 D) . This potentiation of the second response is due to a PKC␤-dependent desensitization (i.e., a "long-term memory" of the first stimulation) and not to a direct effect of the short treatment with the PKC inhibitor. Indeed, the application of the PKC inhibitor by itself (e.g., not in coincidence with a first histamine stimulation) does not modify the response to histamine applied 10 min after the pulse with the inhibitor (Fig. 7 C, inset) .
Given the confounding effect of the heterogeneous consumption of the aequorin probe during the first stimulation, we wished to confirm these results using a radically different probe that is endowed with higher affinity (and thus could ] m responses) but is not consumed during repetitive agonist stimulations. We used a mitochondrially targeted Camgaroo (mtCamgaroo-2), an insertional mutant of GFP sensitive to Ca 2ϩ (Griesbeck et al., 2001) . HeLa cells were transfected with mtCamgaroo-2, analyzed with an imaging system based on a highly sensitive camera, and treated with the double stimulation protocol used for the aequorin experiments. With this mitochondrial Ca 2ϩ probe, the second histamine response is reduced to ‫%81ف‬ (compared with the first one) in control cells (n ϭ 18, P Ͻ 0.05), whereas no difference in the mitochondrial response was detectable in the presence of the PKC␤ inhibitor hispidin (n ϭ 16, P Ͼ 0.05).
Discussion
PKCs comprise a closely related set of enzymes activated by Ca 2ϩ and/or diacylglycerol (i.e., second messengers produced upon engagement of Gq-coupled plasma membrane receptors; Mellor and Parker, 1998) . Molecular diversity within the PKC protein family (underlying different molecular targets and mechanisms of activation) and/or specific tissue or subcellular distribution of the isozymes make these Ca 2ϩ transducers a versatile toolkit, which allows stimulation of different receptors to convert into very diverse cellular effects (Dekker et al., 1995; Toker, 1998; Parekh et al., 2000; Shirai and Saito, 2002) . For example, PKC␣ and ␦ have been demonstrated to have diametrically opposite effects on the process of apoptosis (Ruvolo et al., 1998; Majumder et al., 2000) .
However, PKC participates in Ca 2ϩ signaling not only by activating downstream effectors (enzymes, channels, and transcription factors; Ben Ari et al., 1992; Jaken, 1996; Moscat et al., 2003) but also by shaping the spatio-temporal properties of the Ca 2ϩ signal itself, highlighting a complex interplay between the ion second messenger and its decoding machinery. First, the changes in intracellular Ca 2ϩ concentration and the timing of PKC activation were shown to exhibit different kinetics. Oancea and Meyer (1998) showed that activation of the Ca 2ϩ -sensitive PKC␥ required the displacement of an inhibitor pseudosubstrate; thus, PKC activation (and ensuing cellular response) lagged behind agonist stimulation. This observation implies that repetitive Ca 2ϩ spikes may be necessary for maximal PKC recruitment, and agonist specific spiking frequencies (that can have results varying from sustained PKC recruitment to no mobilization at all) can be differentially decoded inside the cell (Oancea and Meyer, 1998) . Moreover, in an elegant paper, Mogami et al. (2003) show how, in pancreatic ␤ cells, the short-lived Ca 2ϩ signal is transduced via PKC activation into long-term phosphorylation of substrate with important implications for the control of important phenomena such as insulin secretion.
Second, the Ca 2ϩ response itself can be modified by a previous activation of PKC. This notion is supported by the presence of consensus sequences for PKC phosphorylation in important proteins related with Ca 2ϩ homeostasis such as the IP3 receptor (Willems et al., 1989; Nucifora et al., 1995) , the Ca 2ϩ ATPase of the plasma membrane (Zylinska et al., 1998) , and several agonist receptors (Francesconi and Duvoisin, 2000) . This modulatory effect was recently demonstrated by Montero et al. (2003) , who showed that PKC inhibition (through the use of a wide-spectrum blocker that guaranteed the inhibition of all isozymes) drastically reduced the agonist-dependent Ca 2ϩ responses in HeLa cells. The data clearly indicated a major role for PKC in tuning the intensity of Ca 2ϩ signals through an effect on the release kinetics of the agonist-sensitive Ca 2ϩ store. In this work, we have investigated two main aspects. First, we have separately analyzed the effect of various PKC isoforms belonging to different subgroups of the protein family on the cellular Ca 2ϩ signaling patterns. Second, we took advantage of organelle-specific Ca 2ϩ probes (the targeted chimeras of the Ca 2ϩ -sensitive photoprotein aequorin) to investigate if some PKC isoform can exert a specific effect on the different Ca 2ϩ pools, thus altering the cross talk between the various reservoirs of this signaling ion. We devoted special attention to mitochondria, which is an important decoding checkpoint of Ca 2ϩ signals (Duchen, 2000; Rizzuto et al., 2000) . Indeed, Ca 2ϩ increases in the mitochondrial matrix, Figure 7 . Effect of PKC␤ inhibitor hispidin on the reduction of mitochondrial Ca 2ϩ accumulation occurring upon repeated agonist stimulation. Mitochondrial (A and C) and cytosolic (B and D) [Ca 2ϩ ] was monitored in PKC␤-overexpressing cells as in Fig. 1 and 3 , respectively. Where indicated, the cells were treated with 100 M histamine and 5 M hispidin (PKC␤ inhibitor).
which are triggered by agonist stimulation but also by apoptotic agents such as ceramide, can induce, within the organelle, effects as diverse as stimulation of organelle metabolism (Hajnoczky et al., 1995; Jouaville et al., 1999) and morphological alterations, with the ensuing release of caspase cofactors and the induction of apoptotic cell death (Szalai et al., 1999; Pinton et al., 2001) . Moreover, mitochondrial Ca 2ϩ uptake influences the properties of cytoplasmic Ca 2ϩ increases by either forming a firewall that prevents or delays the spread of Ca 2ϩ waves (Tinel et al., 1999) or rapidly clearing Ca 2ϩ at ER-mitochondria contacts, reducing the (positive or negative) feedback activity of Ca 2ϩ on the ER release channels . Finally, it was recently proposed that Ca 2ϩ release from mitochondria (through the activation of the mitochondrial Na ϩ -Ca 2ϩ exchanger) induces a Ca 2ϩ rise in presynaptic endings, which contributes to posttetanic potentiation of neurotransmitters release (Yang et al., 2003) . For these reasons, the specific modulation of the capacity of mitochondria to accumulate or release Ca 2ϩ (without affecting the global Ca 2ϩ responses of the cell) can greatly increase the flexibility of this signaling pathway.
The detailed analysis of the different PKC isoforms (obtained by overexpressing a specific isozyme or inhibiting it specifically in wild-type cells, two complementary approaches that provided a coherent picture) revealed defined, differentiated roles for the various members of the protein family. A preliminary observation is that subunits belonging to the same subgroup (e.g., ␣ and ␤, and ␦ and ) had very different effects, indicating that PKC-dependent modulation of Ca 2ϩ signaling is based on the recruitment of highly specific substrates or second messenger production patterns. In the case of PKC, no alteration was observed in either the steady-state [Ca 2ϩ ] levels of resting cells or in the changes occurring upon cell stimulation in any of the investigated compartments (ER, Golgi apparatus, cytosol, and mitochondria), indicating that the modulation of cellular Ca 2ϩ signals is not a general property shared by all PKC isoforms. In the case of PKC␣, a major reduction was observed in the amplitude of Ca 2ϩ responses induced by histamine stimulation. Although the resting levels in the ER and Golgi Ca 2ϩ stores were the same of control cells, the drop in luminal [Ca 2ϩ ] was much smaller, and consequently the Ca 2ϩ rises occurring in the cytosol and in the mitochondria were significantly reduced. We have not investigated where this desensitization of global Ca 2ϩ signals occurs (i.e., at the level of receptor, G protein, phospholipase C, or IP3-receptor); however, we note that these results closely match those of Montero et al. (2003) , suggesting that the increase of Ca 2ϩ responses that they observe upon application of wide-spectrum PKC inhibitors (Montero et al., 2003) most likely reflects the inhibition of PKC␣.
However, the most surprising results were obtained with PKC␤, ␦, and . Indeed, when the activity of these isoforms was enhanced (by overexpression) or inhibited, the effect was almost exclusively on mitochondrial Ca 2ϩ uptake. Indeed, although no significant alteration was detected in ER Ca 2ϩ release (and in the amplitude and kinetic properties of the [Ca 2ϩ ] c rise), mitochondrial [Ca 2ϩ ] transients were reduced by PKC ␤ and ␦ and increased by PKC . Unfortunately, it is very difficult to verify which is the molecular site of this regulation, as the most plausible targets are still undefined at the molecular level. Indeed, the Ca 2ϩ transport system of the inner mitochondrial membrane, characterized in terms of biochemical properties (an electrogenic uniporter for accumulation, an exchanger with Na ϩ or H ϩ for release), are still unknown, and consequently no information is available also on regulatory proteins that can interact with them and influence their activity. We have investigated whether or not the alteration of mitochondrial Ca 2ϩ responses could be indirect, i.e., affecting either the three-dimensional structure of the organelle (and thus the possibility of establishing close contacts with the ER Ca 2ϩ store ] that allow fast Ca 2ϩ accumulation into mitochondria) or the driving force for the uptake of the cation (e.g., affecting the expression or activity of uncoupling proteins). On the former aspect, using TMRM to label the organelle, we observed no alteration of the three-dimensional mitochondrial network on expression of any of the PKC isoforms used in our work. As to the driving force, mitochondrial membrane potential was directly measured with ⌬⌿ m -sensitive dyes and indirectly assessed through ROS production. No increase was detected with the isoform, nor decrease with the ␦, whereas a probably modest decrease in ⌬⌿ m was detected in cells overexpressing the ␤ isoforms. Thus, an indirect effect through ⌬⌿ m can be excluded in the former case, whereas it is possible that the sharp decrease of [Ca 2ϩ ] m responses induced by PKC␤ is in part mediated by a reduction of the driving force for Ca 2ϩ accumulation. Conversely, the primary effect of the PKC, and most likely of PKC␦, appears to be on mitochondrial Ca 2ϩ uptake, and its clarification awaits the molecular definition of this important process.
Finally, we investigated if this regulatory mechanism could be responsible for the well-known phenomenon of mitochondrial desensitization to repetitive agonist stimulation described in cell systems as diverse as pancreatic ␤-cells (Nesher and Cerasi, 1987; Anello et al., 1996; Kennedy et al., 1996) and skeletal myotubes (Challet et al., 2001 ; whereas in HeLa cells it was observed only in some experimental conditions [Collins et al., 2001; Filippin et al., 2003] ). In brief, a second stimulation with an agonist causing a [Ca 2ϩ ] c rise induces a drastically reduced [Ca 2ϩ ] m transient that cannot be fully accounted for by receptor desensitization but must be ascribed to a reduced Ca 2ϩ uptake capacity of the organelle. This phenomenon was shown to have important physiological implications, as it correlates in pancreatic ␤ cells with a major reduction in insulin secretion (Maechler et al., 1998) , but no information on the possible mechanism was available. In this contribution, we provide evidence that mitochondrial Ca 2ϩ desensitization can be ascribed to PKC isoforms that are activated by stimulation of receptors coupled to the production of diacylglycerol and IP3 (and thus cause a Ca 2ϩ signal) and induce a reduction in the capacity of mitochondria to rapidly accumulate Ca 2ϩ . A regulatory mechanism based on PKC-dependent phosphorylation can also explain the fact that in permeabilized cells such a desensitization was not observed , as in this case cytosolic proteins, such as PKCs, are lost.
In conclusion, the results of this paper reveal specific roles of the various PKC isoforms in shaping the Ca 2ϩ signals evoked by agonist stimulation in different Ca 2ϩ pools and cellular domains. In particular, the activity of defined PKC isoforms was shown to modulate mitochondrial responses, while leaving global Ca 2ϩ signals unaffected. Thus, mitochondria emerge as a "sink" of Ca 2ϩ released from the ER or entering through plasma membrane channels endowed with unique properties. On the one hand, they participate in decoding Ca 2ϩ -linked agonist stimulations (through intra-and extramitochondrial effects); on the other hand, they can vary their response based on the convergence of PKC-mediated (and possibly other) signaling pathways. Although future work will address the molecular targets of this regulatory mechanism, these results may already highlight novel pharmacological routes for specifically modifying Ca 2ϩ -dependent cellular dysfunctions that occur in a variety of genetic and acquired human disorders.
Materials and methods
Cell culture and transfection
HeLa cells were grown in DME supplemented with 10% FCS in 75 cm 2 Falcon flasks. For aequorin measurements, the cells were seeded before transfection onto 13-mm glass coverslips and allowed to grow to 50% confluence. At this stage, transfection with 4 g of plasmid DNA (control cells: 3 g mtGFP ϩ 1 g AEQ; PKC-overexpressing cells: 3 g PKC-GFP chimera of interest ϩ 1 g AEQ) was performed as described previously and aequorin measurements were performed 36 h after transfection. For ⌬⌿ m , ROS production, and fura-2 measurements, the cells (seeded onto 24-mm coverslips) were transfected with 8 g PKC-GFP plasmid. For single cells [Ca 2ϩ ] m measurements, HeLa cells were seeded onto 24-mm coverslips and transfected with 8 g mtCamgaroo-2 (Griesbeck et al., 2001).
Aequorin measurements
For cytosolic aequorin (cytAEQ) and mitochondrial aequorin (mtAEQ) measurements, the coverslip with the cells was incubated with 5 M coelenterazine for 1-2 h in DME supplemented with 1% FCS and transferred to the perfusion chamber. For reconstituting with high efficiency the aequorin chimeras targeted to the Golgi apparatus and the ER (GoAEQ and erAEQ, respectively), the luminal [Ca 2ϩ ] of these compartments must first be reduced. This result was obtained by incubating the cells for 1 h at 4ЊC in KRB (Krebs-Ringer modified buffer: 125 mM NaCl, 5 mM KCl, 1 mM Na 3 PO 4, 1 mM MgSO 4, 5.5 mM glucose, and 20 mM Hepes, pH 7.4, at 37ЊC) supplemented with 5 M ionomycin and 600 M EGTA in the presence of 5 M coelenterazine n. After this incubation, the cells were extensively washed with KRB supplemented with 2% BSA and 1 mM EGTA. All aequorin measurements were performed in KRB supplemented with 1 mM CaCl 2 (KRB/Ca 2ϩ ). Agonists and other drugs were added to the same medium, as specified in the figure legends. The experiments were terminated by lysing the cells with 100 M digitonin in a hypotonic Ca 2ϩ -rich solution (10 mM CaCl 2 in H 2 O), thus discharging the remaining aequorin pool. The light signal was collected and calibrated into [Ca 2ϩ ] values as described previously Barrero et al., 1997) . All the results are expressed as means Ϯ SEM.
Measurements of ⌬⌿ m , ROS production, and microscopic analysis of mitochondrial structure ROS production in control and PKC-transfected cells was measured with the ROS-sensitive fluorescent probe 5-(and 6)-chloromethyl-2',7'-dichlorohydrofluoresceindiacetate (CM-H 2 DCFDA). The acetate group of CM-H 2 DCFDA is hydrolyzed by esterases inside the cell and it is trapped as a nonfluorescent probe (CM-H 2 DCF). Then, ROS increases its fluorescence. Cells were incubated with 2 M CM-H 2 DCFDA for 20 min and washed with KRB/Ca 2ϩ . The green emission of CM-DCF was recorded at 520 nm. Acquisitions were made every 1 s (exposure time 100-200 ms). After a few minutes, when the rate of free radical production was constant, 300 nM FCCP was added to depolarize mitochondria (drastically reducing mitochondrial ROS production), and the measurements were continued for a few other minutes. The difference between the rates of ROS production before and after FCCP addition reflected the mitochondrial contribution to cellular ROS production (expressed as a percentage of total production). Images were recorded using a digital imaging system based on a fluorescence microscope (model Axiovert 200; Carl Zeiss MicroImaging, Inc.) equipped with a back-illuminated CCD camera (Roper Scientific), excitation and emission filterwheels (Sutter Instrument Company), and piezoelectric motoring of the z stage (Physik Instrumente; GmbH & Co.) . The data were acquired and processed using the MetaFluor analyzing program (Universal Imaging Corp.). ⌬⌿ m was measured using 10 nM TMRM on a confocal microscope (model LSM 510; Carl Zeiss MicroImaging, Inc.). The signal was collected as total emission Ͼ570 nm. To distinguish control from PKC-GFPtransfected cells, green emission was collected in the range Ͼ505-Ͻ535 nm. Mitochondrial structure of control and PKC-transfected cells was studied on a confocal microscope after loading 10 nM TMRM. Red and green signals (visualizing mitochondrial structure and identifying transfected cells, respectively) were collected as described in the previous paragraph.
Fura-2 measurements
The coverslip with PKC-transfected HeLa cells was incubated with 5 M fura-2 (added to DME ϩ 1% FCS) at 37ЊC for 30 min. After a brief wash with KRB/Ca 2ϩ , they were placed in an open Leyden chamber on the thermostated stage of an inverted microscope (model Axiovert; Carl Zeiss MicroImaging, Inc.) equipped with a Sutter filterwheel and 340/380 excitation filters. The fluorescence data were collected with a back-illuminated camera (Princeton Instruments) and expressed as emission ratios using the Metafluor software (Universal Imaging Corp.). Within the microscope field, transfected and untransfected cells were identified before carrying out the fura-2 monitoring by revealing the fluorescence of mtGFP, cotransfected with the PKC isoform of interest.
[Ca 2ϩ
] measurements with mtCamgaroo-2
The coverslip with the mtCamgaroo-2-transfected cells were placed in an open Leyden chamber on the thermostated stage of an inverted microscope equipped with a Sutter filterwheel. The fluorescence data were collected with a back-illuminated camera using the Metafluor software. The time of illumination was reduced to a minimum (50 ms) and at least 1 s between two successive illuminations were allowed to avoid the well-known phenomenon of photoconversion of the probe into a form almost completely insensitive to Ca 2ϩ changes, as reported by Filippin et al. (2003) .
